Bull
$56.20
Szenariopreis
$69.550
+0.223 (+0.32%)Zum Schluss
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Establishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.
Citi
$92
2026-08-13
Citi
2026-08-13
Kursziel
$92
Canaccord
$105
2026-08-07
Canaccord
2026-08-07
Kursziel
$105
Mizuho
$105
2026-07-15
Mizuho
2026-07-15
Kursziel
$105
Citi
$92
2026-07-08
Citi
2026-07-08
Kursziel
$92
BTIG
$90
2026-05-07
BTIG
2026-05-07
Kursziel
$90
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Global Medical Aesthetics Market Poised for Significant Growth

Global Medical Aesthetics Market Poised for Significant Growth

Jim Cramer's Insights on Five Stocks

Latest Wall Street Rating Updates

Conexeu Sciences Targets Regenerative Medicine Market with Innovative Platform
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.